Centiva Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,794
Closed -$947K 1553
2025
Q3
$947K Buy
50,794
+1,019
+2% +$19K 0.01% 510
2025
Q2
$918K Buy
49,775
+213
+0.4% +$3.78K 0.02% 657
2025
Q1
$866K Sell
49,562
-103,265
-68% -$1.74M 0.03% 565
2024
Q4
$2.65M Buy
152,827
+55,029
+56% +$1M 0.05% 210
2024
Q3
$1.82M Buy
97,798
+36,324
+59% +$612K 0.04% 501
2024
Q2
$947K Buy
61,474
+14,641
+31% +$209K 0.02% 811
2024
Q1
$692K Buy
+46,833
New +$648K 0.02% 844
2021
Q2
Sell
-26,775
Closed -$465K 1595
2021
Q1
$465K Buy
26,775
+16,640
+164% +$293K 0.02% 601
2020
Q4
$176K Buy
10,135
+46
+0.5% +$734 0.01% 801
2020
Q3
$139K Buy
+10,089
New +$148K 0.01% 633

Other funds holding SBRA

Centiva Capital's SBRA Position: Q4 2025 in Review

Centiva Capital sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 50,794 shares — an estimated $947K sold.

Centiva Capital first reported a position in SBRA in Q3 2020 and held it in 10 quarters. The position peaked at $2.65M in Q4 2024. 440 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Centiva Capital reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Centiva Capital sold 50,794 Sabra Healthcare REIT shares in Q4 2025, an estimated $947K.
  • Centiva Capital first reported a position in Sabra Healthcare REIT in Q3 2020 and held it in 10 quarters.
  • Centiva Capital's Sabra Healthcare REIT position peaked at $2.65M in Q4 2024.
  • 440 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.